Who owns Cipladine?
Cipladine is owned by Cipla (India, NSE: CIPLA).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Cipla Limited Integrated Annual Report 2025-26. Last checked .
Key facts
- Current owner
- Cipla Limited reported
- Owner HQ
- 🇮🇳 India, Mumbai
- Origin
- 🇮🇳 India
- Category
- Consumer health › First aid & wound care › Bandages & wound care
- Parent ticker
- NSE: CIPLA BSE: 500087
- Last verified
- · 2 sources
About Cipladine
Cipladine is a medicated antiseptic sold in India by Cipla Health, Cipla's wholly owned consumer health subsidiary, which markets it as first aid for skin problems. Cipla's 2025-26 annual report ranks it first among medicated ointments on AC Nielsen estimates, and Cipla Health calls it India's number one medicated antiseptic.
Ownership timeline of Cipladine
Where Cipladine sits in Cipla
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Cipla ownership tree →
See the full Cipla brand portfolio (7) →
Other brands owned by Cipla
Cipla controls 7 brands on Brandtree, 5 of them in consumer health.
Also in consumer health
Other brands in bandages & wound care, and who owns them
The 21 brands in bandages & wound care on Brandtree belong to 13 owners. The largest is HARTMANN, with 4.
| Brand | Owner | Owner based in |
|---|---|---|
| Atrauman | HARTMANN | 🇩🇪 Germany |
| Biatain | Coloplast | 🇩🇰 Denmark |
| Aquacel | Convatec | 🇬🇧 United Kingdom |
| Allevyn | Smith+Nephew | 🇬🇧 United Kingdom |
| Nexcare | 3M | 🇺🇸 United States |
| Hansaplast | Beiersdorf | 🇩🇪 Germany |
| Pantinol Plus | Birzeit Pharmaceutical | 🇵🇸 Palestine |
| Makiron | Daiichi Sankyo Healthcare | 🇯🇵 Japan |
About the owner: Cipla
Cipla is a publicly listed company headquartered in Mumbai, India, founded in 1935. Brandtree records 7 brands under its control, and it is listed as NSE: CIPLA and BSE: 500087.
Cipla is a Mumbai drugmaker founded by Dr K A Hamied in August 1935. Its 2025-26 annual report calls it India's third-largest pharmaceutical company and second in the South African prescription market, with 48 manufacturing sites and over 31,000 permanent employees. Consolidated revenue was ₹28,163 crore in the year to 31 March 2026. Its Indian consumer health business is run by a wholly owned subsidiary, Cipla Health Limited.
🇮🇳 Cipladine and other Indian brands
Brandtree records a controlling owner for 279 brands that began in India. 9 of them (3%) are now controlled by a company headquartered in another country; Cipladine is not one of them.
- Ascoril — Glenmark 🇮🇳
- Gas-O-Fast — Mankind Pharma 🇮🇳
- Ibuclin — Dr. Reddy's 🇮🇳
- Mentho Plus — Emami 🇮🇳
- 8PM — Radico Khaitan 🇮🇳
- ACC — Ambuja Cements 🇮🇳
Frequently asked questions
Who is the parent company of Cipladine?
The parent company of Cipladine is Cipla, a publicly listed company headquartered in India.
Is Cipladine Indian?
Yes. Cipladine originated in India and its owner, Cipla, is also headquartered in India.
Is Cipladine still owned by Cipla?
Yes. As of 21 October 2026, Cipladine is still owned by Cipla. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Cipla Limited Integrated Annual Report 2025-26 — Cipla Limited, Annual report; retrieved 21 October 2026.
- [2] Cipla Health — Our Brands — Cipla Health Limited, Official document; retrieved 21 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.